ProfileGDS5822 / ILMN_3161220
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 18% 29% 11% 32% 24% 10% 1% 12% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.418
GSM1276600PDAC Late Ablation Control 217.129
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.211
GSM1276603PDAC Late Ablation 215.632
GSM1276604PDAC Late Ablation 313.424
GSM1303940PDAC Late Ablation_anti-CTLA4 19.710
GSM1303941PDAC Late Ablation_anti-CTLA4 21.11
GSM1303942PDAC Late Ablation_anti-CTLA4 37.612